Annual Total Liabilities
$76.22 B
+$10.54 B+16.05%
December 1, 2024
Summary
- As of February 23, 2025, BMY annual total liabilities is $76.22 billion, with the most recent change of +$10.54 billion (+16.05%) on December 1, 2024.
- During the last 3 years, BMY annual total liabilities has risen by +$2.91 billion (+3.97%).
- BMY annual total liabilities is now -5.44% below its all-time high of $80.60 billion, reached on December 31, 2020.
Performance
BMY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$76.22 B
-$255.00 M-0.33%
December 1, 2024
Summary
- As of February 23, 2025, BMY quarterly total liabilities is $76.22 billion, with the most recent change of -$255.00 million (-0.33%) on December 1, 2024.
- Over the past year, BMY quarterly total liabilities has increased by +$10.54 billion (+16.05%).
- BMY quarterly total liabilities is now -7.60% below its all-time high of $82.48 billion, reached on March 31, 2024.
Performance
BMY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BMY Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.1% | +16.1% |
| 3 y3 years | +4.0% | +16.1% |
| 5 y5 years | -2.6% | +16.1% |
BMY Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.1% | -7.6% | +24.0% |
| 5 y | 5-year | -5.4% | +16.1% | -7.6% | +24.0% |
| alltime | all time | -5.4% | +2662.4% | -7.6% | +2662.4% |
Bristol-Myers Squibb Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $76.22 B(+16.1%) | $76.22 B(-0.3%) |
| Sep 2024 | - | $76.47 B(-1.4%) |
| Jun 2024 | - | $77.58 B(-5.9%) |
| Mar 2024 | - | $82.48 B(+25.6%) |
| Dec 2023 | $65.67 B(-0.0%) | $65.67 B(+5.6%) |
| Sep 2023 | - | $62.20 B(+1.2%) |
| Jun 2023 | - | $61.46 B(-1.5%) |
| Mar 2023 | - | $62.40 B(-5.0%) |
| Dec 2022 | $65.70 B(-10.4%) | $65.70 B(+0.4%) |
| Sep 2022 | - | $65.46 B(-3.3%) |
| Jun 2022 | - | $67.70 B(-5.2%) |
| Mar 2022 | - | $71.39 B(-2.6%) |
| Dec 2021 | $73.31 B(-9.0%) | $73.31 B(-0.4%) |
| Sep 2021 | - | $73.61 B(-0.4%) |
| Jun 2021 | - | $73.92 B(-1.1%) |
| Mar 2021 | - | $74.76 B(-7.2%) |
| Dec 2020 | $80.60 B(+3.0%) | $80.60 B(+7.0%) |
| Sep 2020 | - | $75.31 B(-4.6%) |
| Jun 2020 | - | $78.92 B(-0.5%) |
| Mar 2020 | - | $79.31 B(+1.4%) |
| Dec 2019 | $78.25 B(+275.1%) | $78.25 B(+97.2%) |
| Sep 2019 | - | $39.68 B(+1.7%) |
| Jun 2019 | - | $39.01 B(+99.9%) |
| Mar 2019 | - | $19.52 B(-6.4%) |
| Dec 2018 | $20.86 B(-3.9%) | $20.86 B(+4.4%) |
| Sep 2018 | - | $19.98 B(-1.2%) |
| Jun 2018 | - | $20.22 B(+0.2%) |
| Mar 2018 | - | $20.18 B(-7.0%) |
| Dec 2017 | $21.70 B(+25.0%) | $21.70 B(+13.9%) |
| Sep 2017 | - | $19.06 B(+2.6%) |
| Jun 2017 | - | $18.59 B(+1.0%) |
| Mar 2017 | - | $18.40 B(+6.0%) |
| Dec 2016 | $17.36 B(+0.2%) | $17.36 B(-3.3%) |
| Sep 2016 | - | $17.95 B(+1.1%) |
| Jun 2016 | - | $17.75 B(+2.4%) |
| Mar 2016 | - | $17.34 B(+0.1%) |
| Dec 2015 | $17.32 B(-7.7%) | $17.32 B(+5.0%) |
| Sep 2015 | - | $16.51 B(-0.9%) |
| Jun 2015 | - | $16.66 B(-6.9%) |
| Mar 2015 | - | $17.89 B(-4.7%) |
| Dec 2014 | $18.77 B(-19.7%) | $18.77 B(+2.8%) |
| Sep 2014 | - | $18.25 B(+0.7%) |
| Jun 2014 | - | $18.12 B(+1.3%) |
| Mar 2014 | - | $17.89 B(-23.4%) |
| Dec 2013 | $23.36 B(+4.9%) | $23.36 B(+5.7%) |
| Sep 2013 | - | $22.09 B(+1.0%) |
| Jun 2013 | - | $21.88 B(-1.7%) |
| Mar 2013 | - | $22.26 B(0.0%) |
| Dec 2012 | $22.26 B(+30.1%) | $22.26 B(+0.5%) |
| Sep 2012 | - | $22.14 B(+39.7%) |
| Jun 2012 | - | $15.86 B(-1.9%) |
| Mar 2012 | - | $16.16 B(-5.5%) |
| Dec 2011 | $17.10 B(+10.8%) | $17.10 B(+9.8%) |
| Sep 2011 | - | $15.58 B(-0.7%) |
| Jun 2011 | - | $15.69 B(+4.9%) |
| Mar 2011 | - | $14.95 B(-3.2%) |
| Dec 2010 | $15.44 B(-4.8%) | $15.44 B(-0.3%) |
| Jun 2010 | - | $15.48 B(-0.3%) |
| Mar 2010 | - | $15.52 B(-4.3%) |
| Dec 2009 | $16.22 B(-6.1%) | $16.22 B(-2.2%) |
| Sep 2009 | - | $16.58 B(+4.5%) |
| Jun 2009 | - | $15.87 B(-4.2%) |
| Mar 2009 | - | $16.56 B(-4.1%) |
| Dec 2008 | $17.28 B(+10.7%) | $17.28 B(+11.2%) |
| Sep 2008 | - | $15.54 B(-10.1%) |
| Jun 2008 | - | $17.29 B(+9.7%) |
| Mar 2008 | - | $15.76 B(+1.0%) |
| Dec 2007 | $15.61 B(+0.2%) | $15.61 B(+4.4%) |
| Sep 2007 | - | $14.95 B(-8.9%) |
| Jun 2007 | - | $16.41 B(+3.7%) |
| Mar 2007 | - | $15.83 B(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $15.58 B(-8.0%) | $15.58 B(-0.3%) |
| Sep 2006 | - | $15.63 B(-0.4%) |
| Jun 2006 | - | $15.69 B(-1.4%) |
| Mar 2006 | - | $15.90 B(-6.1%) |
| Dec 2005 | $16.93 B(-16.3%) | $16.93 B(+18.1%) |
| Sep 2005 | - | $14.34 B(-0.6%) |
| Jun 2005 | - | $14.43 B(-19.9%) |
| Mar 2005 | - | $18.03 B(-10.9%) |
| Dec 2004 | $20.23 B(+14.6%) | $20.23 B(+3.7%) |
| Sep 2004 | - | $19.51 B(+5.2%) |
| Jun 2004 | - | $18.55 B(+4.1%) |
| Mar 2004 | - | $17.83 B(+0.9%) |
| Dec 2003 | $17.66 B(+8.6%) | $17.66 B(+7.3%) |
| Sep 2003 | - | $16.46 B(+1.0%) |
| Jun 2003 | - | $16.30 B(+1.5%) |
| Mar 2003 | - | $16.06 B(-1.2%) |
| Dec 2002 | $16.27 B(-13.2%) | $16.27 B(+3.1%) |
| Sep 2002 | - | $15.77 B(+12.1%) |
| Jun 2002 | - | $14.07 B(-0.8%) |
| Mar 2002 | - | $14.18 B(-24.3%) |
| Dec 2001 | $18.74 B(+123.1%) | $18.74 B(+27.5%) |
| Sep 2001 | - | $14.70 B(+85.2%) |
| Jun 2001 | - | $7.94 B(-3.5%) |
| Mar 2001 | - | $8.22 B(-2.1%) |
| Dec 2000 | $8.40 B(-0.8%) | $8.40 B(+1.0%) |
| Sep 2000 | - | $8.31 B(+5.0%) |
| Jun 2000 | - | $7.91 B(-3.8%) |
| Mar 2000 | - | $8.23 B(-2.9%) |
| Dec 1999 | $8.47 B(-2.6%) | $8.47 B(+3.6%) |
| Sep 1999 | - | $8.17 B(+0.2%) |
| Jun 1999 | - | $8.15 B(-1.0%) |
| Mar 1999 | - | $8.24 B(-5.3%) |
| Dec 1998 | $8.70 B(+12.1%) | $8.70 B(+17.9%) |
| Sep 1998 | - | $7.38 B(+0.4%) |
| Jun 1998 | - | $7.35 B(-8.8%) |
| Mar 1998 | - | $8.06 B(+3.9%) |
| Dec 1997 | $7.76 B(-4.4%) | $7.76 B(-0.4%) |
| Sep 1997 | - | $7.79 B(+1.1%) |
| Jun 1997 | - | $7.71 B(-4.8%) |
| Mar 1997 | - | $8.10 B(-0.2%) |
| Dec 1996 | $8.12 B(+0.1%) | $8.12 B(+6.0%) |
| Sep 1996 | - | $7.66 B(-0.4%) |
| Jun 1996 | - | $7.68 B(-2.6%) |
| Mar 1996 | - | $7.89 B(-2.7%) |
| Dec 1995 | $8.11 B(+12.5%) | $8.11 B(+14.7%) |
| Sep 1995 | - | $7.07 B(-4.1%) |
| Jun 1995 | - | $7.37 B(-1.7%) |
| Mar 1995 | - | $7.50 B(+4.0%) |
| Dec 1994 | $7.21 B(+17.0%) | $7.21 B(+7.6%) |
| Sep 1994 | - | $6.70 B(+7.2%) |
| Jun 1994 | - | $6.25 B(-0.7%) |
| Mar 1994 | - | $6.29 B(+2.0%) |
| Dec 1993 | $6.16 B(+28.8%) | $6.16 B(+30.6%) |
| Sep 1993 | - | $4.72 B(+0.5%) |
| Jun 1993 | - | $4.69 B(+7.4%) |
| Mar 1993 | - | $4.37 B(-8.7%) |
| Dec 1992 | $4.78 B(+32.1%) | $4.78 B(+35.0%) |
| Sep 1992 | - | $3.54 B(+4.0%) |
| Jun 1992 | - | $3.41 B(-0.6%) |
| Mar 1992 | - | $3.43 B(-5.4%) |
| Dec 1991 | $3.62 B(-4.6%) | $3.62 B(+1.4%) |
| Sep 1991 | - | $3.57 B(-1.4%) |
| Jun 1991 | - | $3.62 B(-0.1%) |
| Mar 1991 | - | $3.63 B(-4.5%) |
| Dec 1990 | $3.80 B(+11.3%) | $3.80 B(+1.1%) |
| Sep 1990 | - | $3.75 B(+1.8%) |
| Jun 1990 | - | $3.69 B(+7.6%) |
| Mar 1990 | - | $3.43 B(+0.4%) |
| Dec 1989 | $3.41 B(+2.6%) | $3.41 B(+2.6%) |
| Dec 1988 | $3.33 B(+20.5%) | $3.33 B(+20.5%) |
| Dec 1987 | $2.76 B | $2.76 B |
FAQ
- What is Bristol-Myers Squibb annual total liabilities?
- What is the all time high annual total liabilities for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual total liabilities year-on-year change?
- What is Bristol-Myers Squibb quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly total liabilities year-on-year change?
What is Bristol-Myers Squibb annual total liabilities?
The current annual total liabilities of BMY is $76.22 B
What is the all time high annual total liabilities for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual total liabilities is $80.60 B
What is Bristol-Myers Squibb annual total liabilities year-on-year change?
Over the past year, BMY annual total liabilities has changed by +$10.54 B (+16.05%)
What is Bristol-Myers Squibb quarterly total liabilities?
The current quarterly total liabilities of BMY is $76.22 B
What is the all time high quarterly total liabilities for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly total liabilities is $82.48 B
What is Bristol-Myers Squibb quarterly total liabilities year-on-year change?
Over the past year, BMY quarterly total liabilities has changed by +$10.54 B (+16.05%)